Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study).

Swimberghe, Sandra;Ghislain, Pierre-Dominique;Daci, Evis;Allewaert, Katrien;Abraham, Ivo;et.al.
(2013) Annals of Dermatology —

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 340.42 KB
Request a copy

Details

Authors
Show more
Abstract
Apart from clinical outcomes, the "real-world" outcomes of intermittent short-course cyclosporine treatment remain poorly documented.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Swimberghe, S., Ghislain, P.-D., Daci, E., Allewaert, K., Denhaerynck, K., Hermans, C., Pacheco, C., Vancayzeele, S., Macdonald, K., & Abraham, I. (2013). Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study). Annals of Dermatology. https://doi.org/10.5021/ad.2013.25.1.28